EXAGEN DIAGNOSTICS ($XGN) posted quarterly earnings results for Q3 2026 on Tuesday, November 10th. The company reported earnings of -$0.25 per share, missing estimates of -$0.18 by $0.07. The company also reported revenue of $18,420,000, missing estimates of $18,526,288 by $-106,288.
You can see Quiver Quantitative's $XGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EXAGEN DIAGNOSTICS Insider Trading Activity
EXAGEN DIAGNOSTICS insiders have traded $XGN stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $XGN stock by insiders over the last 6 months:
- JOHN ABALLI (President and CEO) sold 34,294 shares for an estimated $269,790
- JEFFREY G. BLACK (Chief Financial Officer) sold 20,614 shares for an estimated $148,781
- JOREY CHERNETT purchased 14,000 shares for an estimated $104,440
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
EXAGEN DIAGNOSTICS Hedge Fund Activity
We have seen 29 institutional investors add shares of EXAGEN DIAGNOSTICS stock to their portfolio, and 30 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BALYASNY ASSET MANAGEMENT L.P. removed 796,632 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $3,704,338
- FOURWORLD CAPITAL MANAGEMENT LLC added 323,528 shares (+118.5%) to their portfolio in Q2 2026, for an estimated $1,504,405
- FLPUTNAM INVESTMENT MANAGEMENT CO added 288,810 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,342,966
- MARSHALL WACE, LLP added 279,414 shares (+1023.9%) to their portfolio in Q2 2026, for an estimated $1,299,275
- RTW INVESTMENTS, LP removed 200,231 shares (-50.7%) from their portfolio in Q2 2026, for an estimated $931,074
- GSA CAPITAL PARTNERS LLP added 180,175 shares (+521.6%) to their portfolio in Q2 2026, for an estimated $837,813
- RENAISSANCE TECHNOLOGIES LLC removed 163,672 shares (-80.5%) from their portfolio in Q2 2026, for an estimated $761,074
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.